The White House is dropping President Donald Trump’s nomination of Heidi Overton to lead the Food and Drug Administration (FDA) amid a lack of congressional support, as Sen. Roger Marshall (R-KS) is reportedly being considered as a potential replacement.
Axios reported Tuesday evening that the White House had decided to drop Overton’s nomination ahead of a scheduled Wednesday vote by the Senate Health, Education, Labor, and Pensions Committee.
According to a Tuesday report from Semafor, four people familiar with the matter said Republicans are discussing Marshall as a possible replacement for Overton, whose nomination has encountered…
Read the full article at BREITBART.COM








